TOBAM’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,955
Closed -$843K 329
2024
Q2
$843K Buy
+19,955
New +$1.1M 0.13% 98
2023
Q3
Sell
-845
Closed -$79K 383
2023
Q2
$79K Hold
845
0.01% 319
2023
Q1
$57K Buy
+845
New +$54.3K ﹤0.01% 343
2022
Q3
Sell
-3,824
Closed -$151K 447
2022
Q2
$151K Sell
3,824
-35,999
-90% -$1.92M 0.01% 265
2022
Q1
$2.78M Sell
39,823
-1,817
-4% -$133K 0.14% 106
2021
Q4
$3.24M Buy
41,640
+4,622
+12% +$408K 0.15% 98
2021
Q3
$3.53M Sell
37,018
-49,516
-57% -$5.23M 0.15% 95
2021
Q2
$10.8M Sell
86,534
-56,026
-39% -$6.69M 0.43% 68
2021
Q1
$18.8M Buy
142,560
+36,499
+34% +$5M 0.8% 53
2020
Q4
$14.1M Buy
106,061
+94,564
+823% +$11.4M 0.63% 56
2020
Q3
$1.17M Buy
+11,497
New +$993K 0.06% 119
2019
Q3
Sell
-592
Closed -$70K 126
2019
Q2
$70K Sell
592
-1,416
-71% -$143K ﹤0.01% 111
2019
Q1
$174K Sell
2,008
-960
-32% -$81.7K 0.01% 120
2018
Q4
$187K Buy
+2,968
New +$204K 0.01% 134

Other funds holding EXAS

TOBAM's EXAS Position: Q3 2024 in Review

TOBAM sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 19,955 shares — an estimated $843K sold.

TOBAM first reported a position in EXAS in Q4 2018 and held it in 14 quarters. The position peaked at $18.8M in Q1 2021. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • TOBAM reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • TOBAM sold 19,955 Exact Sciences shares in Q3 2024, an estimated $843K.
  • TOBAM first reported a position in Exact Sciences in Q4 2018 and held it in 14 quarters.
  • TOBAM's Exact Sciences position peaked at $18.8M in Q1 2021.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on TOBAM's 13F filing for Q3 2024, filed 9 Oct 2024.